GTG.AX
Genetic Technologies Ltd
Price:  
0.04 
AUD
Volume:  
10,071.00
Australia | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GTG.AX EV/EBITDA

-1257.1%
Upside

As of 2025-05-17, the EV/EBITDA ratio of Genetic Technologies Ltd (GTG.AX) is -0.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTG.AX's latest enterprise value is 9.42 mil AUD. GTG.AX's TTM EBITDA according to its financial statements is -10.22 mil AUD. Dividing these 2 quantities gives us the above GTG.AX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.2x - 11.3x 9.4x
Forward P/E multiples 9.4x - 14.7x 12.3x
Fair Price (0.39) - (0.47) (0.45)
Upside -1106.5% - -1307.3% -1257.1%
0.04 AUD
Stock Price
(0.45) AUD
Fair Price

GTG.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA